Sanara MedTech Reports Q4 2025 Earnings with Revenue Growth and Margin Improvements
Sanara MedTech (SMTI) reported Q4 2025 net revenue of $27.5 million, a 5% year-over-year increase, with gross margin at 93% and operating income of $1.1 million. The company also noted a net loss of $1.1 million for the quarter, driven by noncash IP impairment and increased R&D expenses.
Tickers: $SMTI
Topics: Adjusted EBITDA Earnings Gross Margin Net Loss Operating Expenses Revenue Growth